Trial Profile
Zemaira (Alpha-1-Proteinase Inhibitor) Therapy in HIV-1 Disease
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 30 Sep 2021
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 31 Aug 2021 Phase of the trial has been changed from phase 1 to phase 2/3. Primary end-point is changed from Lymphocyte Phenotype to CD4/CD8 Ratio.
- 13 Jun 2011 New trial record